Akums Drugs Eyes $243M IPO for Strategic Growth & Valuation!
Akums Drugs plans a ₹2,036 crore IPO, valuing it at $1.27 billion. Delve into its growth potential, valuation, and peer comparison.
top of page
- 2 min
Mankind Pharma acquires Bharat Serums and Vaccines for ₹13,630 Crore!
Mankind Pharma’s acquisition of Bharat Serums boosts its pharmaceutical portfolio. Discover the impact and strategic benefits of this deal!
1 view0 comments
- 4 min
Why are Private Equity Firms Acquiring Hospitals in India?
Discover why PE firms are increasingly acquiring hospitals. Explore the strategic reasons and market dynamics fueling this investment surge!
6 views0 comments
bottom of page